NovoCure Limited

NASDAQ: NVCR · Real-Time Price · USD
11.77
0.18 (1.55%)
At close: Aug 15, 2025, 3:05 PM

NovoCure Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
163.77M 240.82M 115.33M 208.8M
Short-Term Investments
796.11M 669.79M 854.1M 728.9M
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
14.62M 14.02M 11.16M 12.09M
Receivables
98.64M 77.11M 86.26M 93.57M
Inventory
35.09M 38.15M 29.38M 24.43M
Other Current Assets
2.33M 1.74M 20.05M 13.07M
Total Current Assets
1.11B 1.03B 1.11B 1.07B
Property-Plant & Equipment
119.59M 97.7M 68.96M 53.88M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
134.21M 111.72M 80.12M 65.97M
Total Assets
1.24B 1.15B 1.19B 1.14B
Account Payables
105.09M 94.39M 85.2M 72.6M
Deferred Revenue
14.22M 16.22M 18.03M 17.76M
Short-Term Debt
558.16M n/a n/a n/a
Other Current Liabilities
n/a n/a n/a n/a
Total Current Liabilities
756.38M 179.12M 158.78M 142.6M
Long-Term Debt
97.3M 568.82M 565.51M 562.22M
Other Long-Term Liabilities
6.96M 8.28M 4.55M 4.71M
Total Long-Term Liabilities
124.23M 604.52M 591.7M 586.4M
Total Liabilities
880.61M 783.63M 750.48M 729M
Total Debt
683.35M 596.24M 584.27M 575.21M
Common Stock
n/a n/a n/a n/a
Retained Earnings
-1.15B -985.5M -778.46M -685.93M
Comprehensive Income
-5.5M -5.47M -2.43M -3.17M
Shareholders Equity
360.18M 362.5M 441.17M 410.49M
Total Investments
796.11M 669.79M 854.1M 728.9M